Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$0.62 - $2.35 $0 - $2
1 New
1 $0
Q2 2022

Jul 25, 2022

SELL
$1.77 - $4.34 $120,648 - $295,827
-68,163 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$4.03 - $12.19 $6,149 - $18,601
-1,526 Reduced 2.19%
68,163 $280,000
Q4 2021

Jan 28, 2022

BUY
$8.76 - $13.71 $610,475 - $955,436
69,689 New
69,689 $896,000

Others Institutions Holding GRTS

About Gritstone bio, Inc.


  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.